Home » Chinese FDA Approves Profound’s Sonalleve
Chinese FDA Approves Profound’s Sonalleve
Profound Medical received an approval from China’s FDA for its Sonalleve, a therapeutic platform used to perform ablation of diseased tissue.
Sonalleve offers women with uterine fibroids a non-invasive therapy that avoids performing hysterectomies in invasive surgery and hospitalization.
The device combines real-time magnetic resonance imaging and thermometry with thermal ultrasound to remove tissue without making incisions.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May